Solomon, V.R.; Barreto, K.; Bernhard, W.; Alizadeh, E.; Causey, P.; Perron, R.; Gendron, D.; Alam, M.K.; Carr, A.; Geyer, C.R.;
et al. Nimotuzumab Site-Specifically Labeled with 89Zr and 225Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers. Cancers 2020, 12, 3449.
https://doi.org/10.3390/cancers12113449
AMA Style
Solomon VR, Barreto K, Bernhard W, Alizadeh E, Causey P, Perron R, Gendron D, Alam MK, Carr A, Geyer CR,
et al. Nimotuzumab Site-Specifically Labeled with 89Zr and 225Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers. Cancers. 2020; 12(11):3449.
https://doi.org/10.3390/cancers12113449
Chicago/Turabian Style
Solomon, Viswas Raja, Kris Barreto, Wendy Bernhard, Elahe Alizadeh, Patrick Causey, Randy Perron, Denise Gendron, Md. Kausar Alam, Adriana Carr, C. Ronald Geyer,
and et al. 2020. "Nimotuzumab Site-Specifically Labeled with 89Zr and 225Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers" Cancers 12, no. 11: 3449.
https://doi.org/10.3390/cancers12113449
APA Style
Solomon, V. R., Barreto, K., Bernhard, W., Alizadeh, E., Causey, P., Perron, R., Gendron, D., Alam, M. K., Carr, A., Geyer, C. R., & Fonge, H.
(2020). Nimotuzumab Site-Specifically Labeled with 89Zr and 225Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers. Cancers, 12(11), 3449.
https://doi.org/10.3390/cancers12113449
